Search clinical trials for: Candesartan Cilexetil

Total 204 results

Karin Skov
AstraZeneca; University of Aarhus

Unknown

Danish Hypertension Prevention Project - DHYPP

Hypertension

Denmark
Third Military Medical University

Unknown

GRK4 Polymorphisms Blood Pressure Response to Candesartan

Essential Hypertension

China
University Hospital, Akershus
University of Oslo; AstraZeneca; Norwegian Cancer Society

Completed

Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA)

Heart Failure | Breast Cancer

Norway
Boehringer Ingelheim

Completed

Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy Volunteers

Healthy
Chong Kun Dang Pharmaceutical

Completed

CKD-330 Drug-Drug Interaction Study (Amlodipine) (CKD-330(A))

Hypertension

Korea, Republic of
Tibotec Pharmaceuticals, Ireland

Completed

A Study to Assess the Anti-viral Activity, Safety, Tolerability and Pharmacokinetics of TMC435350 in Participants Infected With Hepatitis C-Virus (HCV)

Hepatitis C

Belgium, Germany, Thailand
Janssen R&D Ireland

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.

Healthy

United States
AstraZeneca
Takeda

Completed

DIabetic Retinopathy Candesartan Trials (DIRECT)

Type 2 Diabetes
AstraZeneca
Takeda

Completed

DIabetic Retinopathy Candesartan Trials. (DIRECT)

Type 1 Diabetes
Chong Kun Dang Pharmaceutical

Terminated

The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)

Hypertension

Korea, Republic of
Alvogen Korea

Completed

Pharmacokinetic Drug Interaction Between Candesartan and Rosuvastatin

Healthy

Korea, Republic of
HanAll BioPharma Co., Ltd.

Completed

Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg

Hypertension

Korea, Republic of
Norwegian University of Science and Technology
AstraZeneca; St. Olavs Hospital; Kragerø Tablettproduksjon as, Norway

Completed

Candesartan Versus Propranolol for Migraine Prevention

Chronic Migraine | Migraine Without Aura | Migraine With Aura

Norway
Seoul National University Hospital

Unknown

Comparison of Vascular Remodeling Between Different Antianginal Medication Evaluated by Noninvasive ECG-gated Fundus Photographic Evaluation

Stable Angina

Korea, Republic of
Ache Laboratorios Farmaceuticos S.A.

Completed

Efficacy and Safety of Glucosamine Sulfate and Chondroitin Sulfate Combination in Treatment of Knee Osteoarthritis

Knee Osteoarthritis

Brazil
University of Salerno
Federico II University

Unknown

Angiotensin II Antagonist in Severe Sepsis (SartSep)

Severe Sepsis

Italy
Tibotec Pharmaceuticals, Ireland

Completed

TMC435-TiDP16-C113: A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of TMC435

Hepatitis C Virus

United States
Kumamoto University
Japan Heart Foundation; The 4C trial bureau

Completed

Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial

Coronary Artery Disease | Hypertension

Japan
University of Southern California
National Institute on Aging (NIA); Hebrew SeniorLife

Completed

The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial (AVEC)

Hypertension | Cognitive Impairment | Aging

United States
Louise Faerch

Completed

Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin System

Hypoglycemia | Type 1 Diabetes

Denmark
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Genetic Epidemiology of Responses to Antihypertensives (GERA)

Heart Diseases | Cardiovascular Diseases | Hypertension

United States
Fundación Cardiovascular de Colombia
AstraZeneca

Terminated

Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects (ARAMIA)

Obesity | Glucose Intolerance

Colombia
Vanderbilt University

Completed

The RAS, Fibrinolysis and Cardiopulmonary Bypass

Coronary Artery Disease | Inflammation | Cardiopulmonary Bypass | Fibrinolysis | Angiotensin Receptor Blockers | Angiotensin Converting Enzyme

United States
AstraZeneca

Completed

Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone

Heart Failure | Ventricular Dysfunction, Left

Sweden
AstraZeneca

Completed

Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension (ARBACE)

Hypertension | Cardiovascular Disease

Sweden
Montreal Heart Institute
AstraZeneca

Completed

A Pharmacogenomic Study of Candesartan in Heart Failure

Heart Failure

Canada
Novartis

Completed

Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension (AMAZING)

Hypertension

Germany
AstraZeneca

Completed

Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)

Congestive Heart Failure
National Taiwan University Hospital

Unknown

An Investigation on the Effect of Candesartan on Early Diabetic Nephropathy

Diabetic Nephropathy
University of Sydney
National Health and Medical Research Council, Australia

Unknown

The Long-term Evaluation of Glucosamine Sulphate Study (LEGS)

Osteoarthritis, Knee

Australia
Takeda

Completed

Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.

Heart Failure

Germany
Takeda

Terminated

Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart Failure (CANDHEART)

Heart Failure
Yonsei University

Completed

Effect of Candesartan in Alcoholic Liver Fibrosis

Alcoholic Liver Disease

Korea, Republic of
Odense University Hospital

Unknown

Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis

Atrial Fibrillation | Aortic Valve Stenosis | Left Ventricular Hypertrophy

Denmark
University of Helsinki
AstraZeneca

Unknown

The Potential of Candesartan to Retard the Progression of Aortic Stenosis (ROCK-AS)

Aortic Valve Stenosis

Finland
AstraZeneca

Completed

Evaluation of Atacand® (Candesartan) in Daily Medical Practice

Hypertension
US Department of Veterans Affairs
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Completed

Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)

Osteoarthritis

United States
Umeå University
AstraZeneca; Sahlgrenska University Hospital, Sweden

Completed

Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo

Hypertension | Obesity

Sweden
Assistance Publique - Hôpitaux de Paris

Completed

Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker

Healthy

France
University of Pavia

Unknown

Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension

Essential Hypertension

Italy
AstraZeneca

Completed

Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH (CandLE)

Essential Hypertension | Left Ventricular Hypertrophy
AstraZeneca

Completed

Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide (CoCa)

Essential Hypertension
AstraZeneca

Completed

Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age

Pediatric Hypertension

United States, Hungary, Slovakia, Belgium
Università degli Studi dell'Insubria

Unknown

Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine

HIV Infections | Hypertension

Italy
Saitama Medical University

Completed

Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients

Cardiovascular Disease
Providence Health & Services
AstraZeneca

Completed

Angiotensin II Antagonism of TGF-Beta 1

Hypertension | Diabetic Nephropathy

United States
Charles University, Czech Republic
AstraZeneca

Unknown

CHANCE - Candesartan in Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy

Czech Republic
Saitama Medical University
Non-Profit Organaizaion "LINE"

Unknown

Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese Patients

Hypertension

Japan
Asker & Baerum Hospital
Ullevaal University Hospital; AstraZeneca; Helse Ost

Completed

Candesartan in the Prevention of Relapsing Atrial Fibrillation

Atrial Fibrillation

Norway
Technische Universität Dresden

Completed

Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone.

Healthy Subjects

Germany

3

Subscribe